Author

H. Ishiwata-Endo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:development & morphogenesis· 2 Approach:experimental assay· 2 Organism:mouse· 2 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

J. Kato· 3 shared J. Moss· 3 shared C. Liu· 2 shared M. J. Lizak· 2 shared Z.-X. Yu· 2 shared A. Noguchi· 1 shared C. Chea· 1 shared D. A. Springer· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. Kato

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ADP-ribose-acceptor hydrolase 2 (Arh2) deficiency results in cardiac dysfunction, tumorigenesis, inflammation, and decreased survival

J. Kato, S. Yamashita, H. Ishiwata-Endo, S. Oka, Z.-X. Yu, C. Liu, D. Springer, A. Noguchi, M. Peiravi, V. Hoffmann, M. J. Lizak, M. Medearis, I.-K. Kim, J. Moss

This study shows that Arh2 deficiency leads to cardiac dysfunction, tumorigenesis, inflammation, and reduced survival in mice.

bioRxiv · Feb 7, 2023 · PreprintCancer Biology

Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates

C. Chea, D.-Y. Lee, J. Kato, H. Ishiwata-Endo, J. Moss

This study identifies SARS-CoV-2 Mac1's ability to hydrolyze specific ADP-ribosylated substrates, revealing its role in disrupting host ADP-ribosylation pathways and potential as a therapeutic target.

bioRxiv · Feb 7, 2023 · PreprintBiochemistry

Mono-ADP-ribosyltransferase 1 (Artc1)-deficiency decreases tumorigenesis, increases inflammation, decreases cardiac contractility, and reduces survival

H. Ishiwata-Endo, J. Kato, H. Oda, J. Sun, Z.-X. Yu, C. Liu, D. A. Springer, P. K. Dagur, M. J. Lizak, E. Murphy, J. Moss

bioRxiv · Feb 6, 2023 · PreprintCancer Biology